RECURSION PHARMACEUTICALS IN
RXRX·75629V104·US·Common Stock·Healthcare - Biotechnology-Activist
RXRX (RECURSION PHARMACEUTICALS IN) is held by 154 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($184.6M), ARK Investment Management LLC ($151.7M), STATE STREET CORP ($127.4M). Net institutional sentiment: Mixed.
154
Holders
(12 Elite)
$1.2B
Total Value
58% (161)
Consensus
94 buying - 67 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 16, 2026 · Insiders Oct 7, 2026 · Activists Aug 7, 2026 · Congress none
InsiderHRHERSHBERG ROBERTExercise 25K shOct 6, 2026
InsiderHRHERSHBERG ROBERTSell $125KOct 6, 2026
InsiderBBBorgeson BlakeSell $242KOct 6, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 169
1 / 9
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer